Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-12-11

FDA Approved: OXCARBAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' original application for oxcarbazepine, a generic anticonvulsant indicated for partial-onset seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)